Since ADOA exhibits heterogeneous phenotypes12,27 and as it is a rare disease, making it difficult to obtain primary neutrophils from patients, we pursued a genetic approach to investigate more closely the role of OPA1 in DNA release and NET formation. The gene discussed is OPA1; the disease is autosomal dominant optic atrophy.